CYTK Cytokinetics, Inc.
Biotechnology NasdaqGS
Trading Signals (CYTK)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $29.57
- Medium Support $30.83
- Weak Support $32.1
Resistance Levels
- Weak Resistance $34.63
- Medium Resistance $35.89
- Strong Resistance $37.16
Stop Loss Suggestions
- Conservative $34.37
- Moderate $35.26
- Aggressive $36.52
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | SELL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (CYTK)
Quarterly Outlook :
2025-07-08
Bullish Scenario
from current 23.83%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
2025-07-08
Base Scenario
from current 2.98%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -23.83%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
Annual Outlook
2025-07-08
Bullish Scenario
from current 47.66%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
2025-07-08
Base Scenario
from current 5.96%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -47.66%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (14.82) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (41.19) is in bearish territory, indicating downward momentum. MACD line (-4.19) is above Signal line (-4.40) (bullish crossover), confirming upward momentum. Current Weekly ATR is 4.13, indicating the average weekly price range.
Technical Analysis (CYTK)
Trend Identification
EMA
Exponential Moving Average
Current price (33.36) is below both Short MA (33.37) and Long MA (34.45). This indicates strong bearish momentum. Short MA (33.37) is below Long MA (34.45), a bearish crossover ('Death Cross' if it's a significant period). This indicates a downward trend. All MAs are in bearish order (Price < Short MA < Long MA < Very Long MA 38.12). This is a strong bearish alignment. Consider short positions. Use the MAs as dynamic resistance levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.1700) is positive and expanding, confirming bullish momentum. MACD and Signal lines are on opposite sides of the zero line, indicating a potential zero-line crossover. This is a significant trend indicator.
ADX
Average Directional Index
ADX (24.27) indicates a developing or weakening trend. +DI (23.79) is above -DI (13.33), suggesting a bullish directional bias. Be cautious with current positions. Monitor for trend continuation or reversal signals.
Momentum Measurement
RSI (2025-07-08)
Relative Strength Index
RSI (49.86) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV (2025-07-08)
On-Balance Volume
OBV (-22867680.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-08)
Stochastic Oscillator
Stochastics (%K: 60.36, %D: 61.93) are in the neutral zone (between 20 and 80). No clear bullish or bearish crossover signal currently. The lines are close or moving sideways.
CCI (2025-07-08)
Commodity Channel Index
CCI (40.98) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2025-07-08)
Average True Range
Current ATR is 1.3800. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-08)
Volatility Bands
Current price (33.36) is within the Bollinger Bands (31.99 - 34.76). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (33.37), indicating short-term bearish bias.
Risk Management & Potential Reversals (CYTK)
SAR (2025-07-08)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 32.51 is 2.55% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-07-08)
Neutral
Stochastic is in neutral territory (60.4). No clear overbought/oversold signal.
RSI (2025-07-08)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-08)
Reversal Perspective
Bands show normal bandwidth. Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (CYTK)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Blackrock Inc. | INSTITUTIONAL | 15563778 | 13.06% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 11849547 | 9.94% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 10316131 | 8.66% | 2025-03-31 |
| T. Rowe Price Investment Management, Inc. | INSTITUTIONAL | 9955251 | 8.35% | 2025-03-31 |
| Wellington Management Group, LLP | INSTITUTIONAL | 7988740 | 6.7% | 2025-03-31 |
| State Street Corporation | INSTITUTIONAL | 6085001 | 5.11% | 2025-03-31 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | MUTUALFUND | 4067922 | 3.41% | 2025-01-31 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | MUTUALFUND | 3821038 | 3.21% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 3747303 | 3.14% | 2025-03-31 |
| Deep Track Capital, Lp | INSTITUTIONAL | 3073853 | 2.58% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | MUTUALFUND | 2946109 | 2.47% | 2025-03-31 |
| Geode Capital Management, LLC | INSTITUTIONAL | 2937484 | 2.46% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 2818686 | 2.36% | 2025-04-30 |
| RTW Investments LP | INSTITUTIONAL | 2721158 | 2.28% | 2025-03-31 |
| Bank of America Corporation | INSTITUTIONAL | 2702874 | 2.27% | 2025-03-31 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | MUTUALFUND | 1982700 | 1.66% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 1817339 | 1.52% | 2025-03-31 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 1763084 | 1.48% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | MUTUALFUND | 1652319 | 1.39% | 2025-03-31 |
| Fidelity Advisor Series I-Fidelity Advisor Growth Opportunities Fund | MUTUALFUND | 1426700 | 1.2% | 2025-05-31 |